DCAF12 Ubiquitin Ligase Promotes Lung Cancer Metastasis by Modulating the TRiC/CCT Chaperonin Complex. [PDF]
Wang Z +13 more
europepmc +1 more source
Ubiquitin E3 ligase MARCH10 targets influenza hemagglutinin for ubiquitination
Tsai, MuChun +6 more
openaire +2 more sources
The E3 ubiquitin ligase, RNF219, suppresses CNOT6L expression to exhibit antiproliferative activity. [PDF]
Soeda S +9 more
europepmc +1 more source
The ubiquitin ligase NKLAM promotes apoptosis and suppression of cell growth. [PDF]
Willard PA, Kornbluth J.
europepmc +1 more source
The E3 ubiquitin ligase MARCH9 alleviates pyroptosis by regulating NLPR3 ubiquitination following myocardial ischemia reperfusion. [PDF]
Lu H +9 more
europepmc +1 more source
Expression of Concern: Rad18 E3 ubiquitin ligase activity mediates Fanconi anemia pathway activation and cell survival following DNA Topoisomerase 1 inhibition. [PDF]
europepmc +1 more source
Related searches:
The selectivity of the ubiquitin–26 S proteasome system (UPS) for a particular substrate protein relies on the interaction between a ubiquitin-conjugating enzyme (E2, of which a cell contains relatively few) and a ubiquitin–protein ligase (E3, of which there are possibly hundreds).
Helen C, Ardley, Philip A, Robinson
openaire +2 more sources
The structure of a giant ubiquitin E3 ligase sheds light on its activation in a substrate-dependent manner and shows how a single E3 enzyme uses distinct recognition modules to confer substrate specificity.
openaire +2 more sources
On ubiquitin ligases and cancer
Human Mutation, 2005Protein kinase genes account for almost 10% of all currently known cancer genes, highlighting the role of signal transduction in oncogenesis. A reexamination of the literature and available databases shows that E3 ubiquitin ligases are also key mediators of tumorigenesis. Altogether kinase and E3 genes represent more than 15% of the known cancer genes,
Jacques S, Beckmann +3 more
openaire +2 more sources
E3 ubiquitin ligase Siah1 aggravates NAFLD through Scp2 ubiquitination
International Immunopharmacology, 2023Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver disorders and accompanied by multiple metabolic dysfunctions. Although excessive lipid accumulation in hepatocytes has been identified as a crucial mediator of NAFLD development, the underlying mechanisms are very complicated and remain largely unknown.
Zhu, Zhu +10 more
openaire +2 more sources

